Iovance Biotherapeutics Signs New Headquarters Lease and Terminates Previous Lease Agreement
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a Delaware-based biotechnology company, has recently announced significant changes in its office locations and lease agreements. On November 15, 2024, the company finalized a sublease agreement with Vaxcyte, Inc. for Suite 100 at 825 Industrial Road, San Carlos, California. This move comes as part of the company’s strategic initiatives to […]
More Stories
How to Build a Cleaning Routine That Helps Reduce Household Dust
Why a Cleaning Routine Matters Household dust has a way of settling everywhere—on floors, countertops, bedding, shelves, and the tops...
The Midterm Fraud Machine: How Corruption, Confusion, and Judicial Abdication Are Stealing America’s 2026 Elections
By Stephen Zogopoulos, USNN World News On November 3, 2026, Americans went to the polls in a midterm election that...
US Economy in Late 2026: Steady Growth, Sticky Inflation, and a Return to Tariff-Based Trade Policy
By Stephen Zogopoulos, USNN World News As of early November 2026, the U.S. economy continues to expand at a moderate...
Major Automakers Side With Trump in Legal Battle Over Eased Fuel Economy Standards
By Kimberly Hayek A major auto industry group has thrown its support behind the Trump administration in a lawsuit brought...
Oil Prices Rise After Reports of Explosions on Iran’s Qeshm Island
By Evgenia Filimianova Oil prices climbed by more than 1.5 percent early on Nov. 3 after reports of explosions on...
Spanish Police Launch Investigation Into Death of Soccer Player After On-field Incident
By Elma Aksalic Spanish authorities have launched an investigation following the death of professional soccer player Jesús de Miguel, who...